Remote possibilities: United BioSource teams with Seqster to boost decentralized study offering

Decentralized trials are here to stay, says United BioSource, which has partnered with “patient centric” healthcare tech firm Seqster PDM to bolster its remote study business.

Under the deal, United BioSource will use Seqster’s aggregation software and access to U.S. healthcare data sources to help customers take advantage of decentralized designs, according to Aaron Berger, executive director of real-world evidence (RWE).